Science and Technology
When will Compass Pathways submit a NDA for COMP360 psilocybin?
COMP360 psilocybin - NDA
Markets
before April 2027
84%
before 2027
80%
before December
74%
Rules
If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.
Outcome verified from Food and Drug Administration.
Additional prohibitions
- Persons who are employed by any of the Source Agencies are not permitted to trade on the Contract.
- Persons who hold any material, non-public information on the Underlying are not permitted to trade on the Contract.
Legal
By trading on this market, you agree to the Trading prohibitions, Member agreement, and DFlow terms of service.